The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality.
Editorial: urology Fecha: 01/06/2010 Lepor H, Lipkin M, Slova D. Acceso al enlace publicador Abstract OBJECTIVES: To critically examine the
Leer más